目前预防心力衰竭再入院和脱补偿性疾病的方法
Matthew Mace1,2, Niklas Lidströmer3,4
1Academy for Healthcare Science (AHCS), Lutterworth, UK - matthewimace@outlook.com.
Minerva cardiology and angiology
|July 5, 2023
概括
监测心内压力提供了一个有前途的策略,以减少心力衰竭入院并改善患者的生活质量. 这种方法提高了资源效率,并可以彻底改变心力衰竭的管理.
科学领域:
- 心脏病学 心脏病学
- 医疗保健服务研究 医疗服务研究
- 生物医学工程 生物医学工程
背景情况:
- 心力衰竭的管理是昂贵的,住院费用超过总开支的80%.
- 尽管采取了远程监测措施,但心力衰竭的住院病例继续增加.
- 有效的再接收减少策略往往侧重于患者教育,自我护理,药物坚持和指导方针导向的医疗治疗.
研究的目的:
- 评估心内压力监测在改善心力衰竭管理效率方面的潜力.
- 探索物理生物标志物对拥堵的远程监测对医院再接收的影响.
- 确定在获得关键血液动力学数据方面需要技术进步,以便及时做出治疗决策.
主要方法:
- 对现有关于患者远程监测和心力衰竭中心内压力监测研究的综述.
- 从使用远程监控设备进行生理生物标志物评估的研究中分析数据.
- 对心力衰竭患者直接血液动力学监测的临床实用性的评估.
主要成果:
- 心内压力监测显示,心力衰竭再入院率显著降低,在偏远环境中改善生活质量.
- 通过生理生物标志物了解拥堵是一种有效的心力衰竭管理策略.
- 直接的血液动力学监测在心力衰竭中提供了具有最高临床实用性的生命体征.
结论:
- 获取心内压力数据可以显著改善心力衰竭管理,特别是在急性住院环境中.
- 在提供低成本,可靠的心内压力监测方面存在技术差距,而无需严重依赖专业资源.
- 获得血液动力学见解的非侵入性方法代表了心力衰竭护理的未来范式转变.
更多相关视频
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.6K
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
6.5K
相关概念视频
01:30Heart Failure V: Medical Management
15
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
15
01:22Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
01:30Heart Failure VII: Nursing Interventions
100
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
100
01:29Cardiomyopathy V: Interprofessional Care
17
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
17
01:30Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
467
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
467